André J. Müller
Director/Miembro de la Junta en Anokion SA .
Cargos activos de André J. Müller
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Director/Miembro de la Junta | - | - |
Historial de carrera de André J. Müller
Antiguos cargos conocidos de André J. Müller.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ADDEX THERAPEUTICS LTD | Presidente | 01/01/2002 | 27/06/2014 |
ACTELION | Director/Miembro de la Junta | 01/01/2009 | 01/01/2009 |
Fundador | 30/12/1999 | 01/04/2009 | |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
REFERENCE CAPITAL SA
REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA. | Director de Inversiones | - | - |
Fundador | - | - | |
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Director/Miembro de la Junta | 01/01/1999 | - |
BIOGEN INC. | Director Financiero/CFO | - | - |
ABIONYX PHARMA | Presidente | - | - |
Formación de André J. Müller.
INSEAD | Masters Business Admin |
University of Geneva | Undergraduate Degree |
Estadísticas
Internacional
Suiza | 7 |
Francia | 3 |
Estados Unidos | 3 |
Operativa
Director/Board Member | 4 |
Chairman | 2 |
Founder | 2 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ADDEX THERAPEUTICS LTD | Health Technology |
ABIONYX PHARMA | Health Technology |
BIOGEN INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Synthes, Inc.
Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
REFERENCE CAPITAL SA
REFERENCE CAPITAL SA Investment ManagersFinance Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA. | Finance |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- André J. Müller
- Experiencia